Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis ClinicalTrials.gov, 18 Jan 2013 Accessed on 11 Aug 2013 from http://www.clinicaltrials.gov/ct2/show/NCT01185821. CommentRecommendBookmarkWatch